Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
26,613,030
-
Share change
-
+20,013,131
-
Total reported value
-
$1,776,088,789
-
Put/Call ratio
-
83%
-
Price per share
-
$66.74
-
Number of holders
-
108
-
Value change
-
+$1,335,873,540
-
Number of buys
-
95
-
Number of sells
-
12
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2020
As of 30 Jun 2020,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,613,030 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, PRIMECAP MANAGEMENT CO/CA/, Artal Group S.A., Artisan Partners Limited Partnership, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, DEUTSCHE BANK AG\, HealthCor Management, L.P., and Candriam Luxembourg S.C.A..
This page lists
108
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.